Literature DB >> 29575417

Translation and validation study for the stroke self-efficacy questionnaire in stroke survivors.

Serpil Topçu1, Sıdıka Oğuz2.   

Abstract

BACKGROUND: Self-efficacy has been shown to play an important role in rehabilitation outcomes of stroke patients. AIM: This study aimed to determine the validity and reliability of a Turkish translation of the Stroke Self-Efficacy Questionnaire.
METHODS: This methodological study was conducted in a private acute stroke unit in Istanbul, Turkey. After obtaining the Institutional Review Board's approval and site consent, a translated version of the 13-item Likert-type scaled questions was tested for language and content validity. A pilot study with 10 patients was followed by recruitment of 130 stroke patient participants, with 50 patients retested after 3 weeks.
RESULTS: The Stroke Self-Efficacy Questionnaire-Turkish had excellent content validity index and face validity index scores. Confirmatory factor analysis findings revealed a single factor structure that offered good model suitability. Cronbach alpha was 0.93 for the scale and its subgroups. There was no statistically significant difference between the items according to test-retest scores (P > 0.05), and a reliability index was over 0.80.
CONCLUSION: The Turkish version of the Stroke Self-Efficacy Questionnaire is a valid and reliable tool, recommended for use in clinical rehabilitation and stroke self-management/self-efficacy interventions.
© 2018 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  questionnaires; rehabilitation; self-efficacy; stroke

Mesh:

Year:  2018        PMID: 29575417     DOI: 10.1111/ijn.12646

Source DB:  PubMed          Journal:  Int J Nurs Pract        ISSN: 1322-7114            Impact factor:   2.066


  1 in total

1.  Self-efficacy instruments for individuals with coronary artery disease: a systematic review protocol.

Authors:  Jose Alexandre Barbosa Almeida; Rêncio Bento Florêncio; Darllane Azevedo Lemos; Jéssica Costa Leite; Karolinne Souza Monteiro; Lucien Peroni Gualdi
Journal:  BMJ Open       Date:  2022-07-26       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.